Model | Medium intensity | High intensity | ||
---|---|---|---|---|
OR | (95% CI) | OR | (95% CI) | |
Survival (among fetuses alive at maternal admission to hospital) | ||||
Baseline | 1.05 | (0.64 – 1.75) | 1.20 | (0.72 – 1.97) |
Baseline + GA | 1.01 | (0.61 – 1.67) | 1.19 | (0.72 – 1.95) |
Baseline + GA + multiple status | 0.99 | (0.60 – 1.64) | 1.15 | (0.70 – 1.89) |
Baseline + extra variables | 0.96 | (0.54 – 1.71) | 1.12 | (0.63 – 2.00) |
Survival without sensorimotor morbidity (among fetuses alive at maternal admission to hospital) | ||||
Baseline | 1.04 | (0.60 – 1.81) | 1.39 | (0.80 – 2.44) |
Baseline + GA | 1.25 | (0.70 – 2.25) | 1.32 | (0.73 – 2.38) |
Baseline + GA + multiple status | 1.20 | (0.67 – 2.14) | 1.27 | (0.70 – 2.28) |
Baseline + extra variables | 1.09 | (0.59 – 2.01) | 1.16 | (0.62 – 2.16) |
CP and sensory disability (among survivors) | ||||
Baseline | 2.04 | (0.73 – 5.75) | 1.53 | (0.54 – 4.37) |
Baseline + GA | 2.11 | (0.73 – 6.11) | 1.54 | (0.52 – 4.50) |
Baseline + GA + multiple status | 2.10 | (0.72 – 6.15) | 1.53 | (0.52 – 4.53) |
Baseline + extra variables | 2.02 | (0.66 – 6.13) | 1.68 | (0.53 – 5.28) |
ASQ below threshold (among survivors) | ||||
Baseline | 1.27 | (0.72 – 2.24) | 0.98 | (0.57 – 1.68) |
Baseline + GA | 1.30 | (0.74 – 2.24) | 0.99 | (0.58 – 1.69) |
Baseline + GA + multiple status | 1.28 | (0.72 – 2.28) | 0.97 | (0.56 – 1.67) |
Baseline + extra variables | 1.35 | (0.76 – 2.40) | 1.01 | (0.58 – 1.76) |